Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer 17 April
PEPFAR and The Global Fund Make Additional Investment in Gilead's Lenacapavir for HIV Prevention to Further Expand Access 14 April
